References
- Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci. 2015;60(3):681–9.
- Siegel RL, Miller KD, Sauer AG, et al. Cancer facts & figures 2020. CA Cancer J Clin. 2020;70(1):7–30.
- National Colorectal Cancer Roundtable. Data & progress: colorectal cancer screening rates. American Cancer Society; 2020. [cited 2020 Aug 1]. Available from: https://nccrt.org/data-progress/#:~:text=The%20UDS%20CRC%20screening%20rate,exceeded%20an%2080%25%20screening%20rate
- Veenstra CM, Regenbogen SE, Hawley ST, et al. A composite measure of personal financial burden among patients with stage III colorectal cancer. Med Care. 2014;52(11):957–962.
- Cancer Intervention and Surveillance Modeling Netowrk (CISNET). Joint profile of colorectal cancer model profiles 2018. [cited 2020 Jan 21] Available from: https://cisnet.flexkb.net/mp/pub/cisnet_colorectal_joint_profile.pdf
- Yabroff KR, Dowling EC, Guy GP, et al. Financial hardship associated with cancer in the USA: findings from a population‐based sample of adult cancer survivors. J Clin Oncol. 2016;34(3):259–267.
- Veenstra CM, Abrahamse P, Wagner TH, et al. Employment benefits and job retention: evidence among patients with colorectal cancer. Cancer Med. 2018;7(3):736–745.
- Claxton G, Rae M, Damico A, et al. Health benefits in 2019: premiums inch higher, employers respond to federal policy. Health Aff. 2019;38(10):1752–1761.
- Gary C, Rae M, Damico A, et al. Employer health benefits: 2019 annual survey. San Francisco, California; Kaiser Family Foundation; 2019. [cited 2020 Jun 10] Available from: http://files.kff.org/attachment/Report-Employer-Health-Benefits-Annual-Survey-2019
- Veenstra CM, Regenbogen SE, Hawley ST, et al. Association of paid sick leave with job retention and financial burden among working patients with colorectal cancer. JAMA. 2015;314(24):2688–2690.
- Islami F, Miller KD, Siegel RL, et al. National and state estimates of lost earnings from cancer deaths in the USA. JAMA Oncol. 2019;5(9):e191460.
- De Moor JS, Cohen RA, Shapiro JA, et al. Colorectal cancer screening in the USA: trends from 2008 to 2015 and variation by health insurance coverage. Prev Med. 2018;112:199–206.
- Cynthia KW, Riffle S, Michaels L, et al. Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol. 2010;8(2):166–173.
- Warren JL, Klabunde CN, Mariotto AB, et al. Adverse events after outpatient colonoscopy in the medicare population. Ann Intern Med. 2009;150(12):849–857.
- Sacks NC, Sharma A, Cyr PL, et al. Real-world comparison of the effectiveness and safety of different bowel preparation agents. Clin Exp Gastroenterol. 2018;11:289–299.
- Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–2575.
- Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American cancer society. CA Cancer J Clin. 2018;68(4):250–281.
- Sheridan SL, Harris RP, Woolf SH. Shared decision-making workgroup of the U.S. preventive services task force. Shared decision making about screening and chemoprevention. A suggested approach from the U.S. preventive services task force. Am J Prev Med. 2004;26(1):56–66.
- Volk RJ, Linder SK, Lopez-Olivio MA, et al. Patient decision aids for colorectal cancer screening: a systematic review and meta-analysis. Am J Prev Med. 2016;51(5):779–791.
- Hathway JM, Miller-Wilson LA, Jensen IS, et al. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives. J Med Econ. 2020;23(6):581–592.
- Bureau of Labor Statistics. Employee Tenure in 2018. US Department of Labor Statistics. Sept 2018. [cited 2020 Jun 1] Available from: https://www.bls.gov/news.release/pdf/tenure.pdf
- Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastroenterology. 2012;143(3):844–857.
- Govani SM, Elliott EE, Menees SB, et al. Predictors of suboptimal bowel preparation in asymptomatic patients undergoing average-risk screening colonoscopy. World J Gastrointest Endosc. 2016;16:616–622.
- Ranasinghe I, Parzynski CS, Searfoss R, et al. Differences in colonoscopy quality among facilities: development of a post-colonoscopy risk-standardized rate of unplanned hospital visits. Gastroenterology. 2016;150(1):103–113.
- Burt RW. Colon cancer screening. Gastroenterology. 2000;119(3):837–853.
- Bureau of Labor Statistics. Average hourly and weekly earnings of all employees on private nonfarm payrolls by industry sector, seasonally adjusted. US Department of Labor Statistics. Sept 2018. [cited 2020 Jun 1] Available from: https://www.bls.gov/news.release/empsit.t19.htm
- Zheng Z, Yabroff KR, Guy GP, et al. Annual medical expenditure and productivity loss among colorectal, female breast, and prostate cancer survivors in the USA. JNCI J Natl Cancer Inst. 2016;108(5):djv382.
- Federal Reserve Bank of St. Louis. Federal reserve economic data St. Louis, MO; 2019. [cited 2019 Jun 1] Available from: https://fred.stlouisfed.org/series/CPIAUCSL#0
- Gifford B, Lin R Disability leaves for five common types of cancer. Integrated benefits institute. March 2018. [cited 2020 Jun 01] Available from: https://www.ibiweb.org/the-work-disability-costs-of-5-common-cancers-engaging-employers-as-public-health-partners/
- Hauglann BK, Benth JS, Fosså SD, et al. A controlled cohort study of sickness absence and disability pension in colorectal cancer survivors. Acta Oncologica. 2014;53(6):735–743.
- HCUP Databases. Healthcare cost and utilization project (HCUP). November 2019. Agency for Healthcare Research and Quality, Rockville, MD. [cited 2020 Aug 01] Available from: www.hcup-us.ahrq.gov/databases.jsp
- Centers for Disease Control and Prevention. Increasing colorectal cancer screening and promoting screening quality: an action guide for engaging employers and professional medical organizations. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2013.
- Jones WF, Dennis JA, Schroy PC. Improving on-time colorectal cancer screening through lead time messaging. Cancer. 2019. DOI:https://doi.org/10.1002/cncr.32535
- Sherman B, Nikka D A new wellness intervention that can increase cancer screening rates for employers. Corporate Wellness Magazine; 2020. [cited 2020 Aug 1] Available from: https://www.corporatewellnessmagazine.com/article/wellness-intervention-cancer-screening
- Young LE, Sacks NC, Cyr PL, et al. Comparison of claims data on hospitalization rates and repeat procedures in patients receiving a bowel preparation prior to colonoscopy. SAGE Open Med. 2017;5:1–8.
- US Bureau of Labor Statistics. Employee access to disability insurance plans. 2018. [cited 2020 Jun 01] Available from: https://www.bls.gov/opub/ted/2018/employee-access-to-disability-insurance-plans.htm
- Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. JAMA. 2016;315(23):2595–2609.